Santhera Pharmaceuticals Holding AG (SWX:SANN)

Switzerland · Delayed Price · Currency is CHF

14.16

-0.28 (-1.94%)

Jul 31, 2026, 5:30 PM CET

SWX:SANN Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22.44	40.93	30.37	1.35	21.21
Cash & Short-Term Investments	22.44	40.93	30.37	1.35	21.21
Cash Growth	-45.17%	34.76%	2144.64%	-93.62%	70.88%
Accounts Receivable	26.04	13.89	2.16	1.09	1.94
Inventory	24.87	17.53	1.81	0.11	0.43
Other Current Assets	6.9	3.48	0.32	0.51	1.07
Total Current Assets	80.24	75.81	34.66	3.07	24.64
Net Property, Plant & Equipment	2.01	2.57	0.58	1.01	1.32
Other Intangible Assets	63.94	68.95	73.97	59.21	64.6
Long-Term Investments	0.32	0.25	0.42	0.44	0.47
Other Long-Term Assets	1.58	4.91	-	0	0.09
Total Assets	148.09	152.49	109.63	63.73	91.12

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	18.01	9.22	5.62	7.58	4.59
Accrued Expenses	19.4	19.35	9.57	10.85	9.71
Current Portion of Long-Term Debt	14.26	6.4	20.94	22.13	15.37
Current Portion of Leases	0.59	0.55	0.57	0.62	0.61
Unearned Revenue	0.14	0.06	-	-	-
Other Current Liabilities	9.78	10.57	9.09	8.23	2.51
Total Current Liabilities	62.17	46.14	45.79	49.41	32.78
Long-Term Debt	72.67	64.89	-	21.08	25.8
Long-Term Leases	1.37	1.94	0.04	0.61	1.2
Other Long-Term Liabilities	22.68	8.79	4.88	39.03	29.57
Total Long-Term Liabilities	97.73	78.65	3.89	58	57.01
Total Liabilities	159.9	124.79	49.69	107.41	89.79

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1.4	1.34	1.26	0.75	54.61
Treasury Stock	-0.06	-0.07	-0.13	-0.09	-5.02
Additional Paid-in Capital	651.96	644.41	630.52	581.12	509.51
Accumulated Other Comprehensive Income	-0.17	-0.27	-0	-0.68	-0.91
Retained Earnings	-663.93	-614.69	-572.72	-627.5	-556.43
Shareholders' Equity	-11.82	27.7	59.94	-43.69	1.33
Total Liabilities & Equity	148.09	152.49	109.63	63.73	91.12

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	88.88	73.79	21.55	44.44	42.98
Net Cash (Debt)	-66.44	-32.86	8.82	-43.08	-21.77
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-5.11	-2.89	0.81	-7.07	-6.37
Book Value	-11.82	27.7	59.94	-43.69	1.33
Book Value Per Share	-0.91	2.43	5.49	-7.17	0.39
Tangible Book Value	-75.75	-41.25	-14.02	-102.89	-63.27
Tangible Book Value Per Share	-5.82	-3.62	-1.28	-16.89	-18.52